Literature DB >> 34779350

What does the Dementia Rating Scale-2 measure? The relationship of neuropsychological measures to DRS-2 total and subscale scores in non-demented individuals with Parkinson's disease.

Francesca V Lopez1, Lauren E Kenney1, Adrianna Ratajska1, Charles E Jacobson2, Dawn Bowers1,2.   

Abstract

OBJECTIVE: The Dementia Rating Scale-2 (DRS-2) is recommended for assessing global cognition in Parkinson's disease (PD) by the Movement Disorder Society. However, empirical evidence is limited regarding the degree to which the DRS-2 corresponds to traditional neurocognitive domains (i.e., construct validity) in PD. Thus, this study aims to determine the construct validity of the DRS-2 in a non-demented sample of PD patients.
METHOD: Patients with PD (n = 359; mean age = 64.50 ± 8.53, education = 14.97 ± 2.73, disease duration = 8.48 ± 4.87, UPDRS Part III motor scale scores = 25.23 ± 10.17) completed the DRS-2 as part of a comprehensive neuropsychological assessment consisting of attention/working memory, executive function, language, delayed recall, and visuoperceptual-spatial skills.Bootstrapped bias-corrected Spearman rho's correlations andhierarchical linear regressions were performed to examine construct validity of DRS-2 total and subscale scores.
RESULTS: Speeded measures of set-shifting, rapid word generation to letter and semantic cues, and simple visuoperceptual skills largely accounted for variance in DRS-2 total scores. Most DRS-2 subscale scores showed weak relationships with theoretically related neuropsychological measures.
CONCLUSIONS: DRS-2 total scores reflect impairment across a range of cognitive domains (i.e., executive, language, and visuoperception), while DRS-2 subscale scores have limited construct validity. Together, the DRS-2 does not appear to have utility beyond screening for global cognition in PD.

Entities:  

Keywords:  DRS-2 subscale score; DRS-2 total score; Parkinson’s disease; construct validity

Year:  2021        PMID: 34779350      PMCID: PMC9107526          DOI: 10.1080/13854046.2021.1999505

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   4.373


  53 in total

1.  Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming.

Authors:  T N Tombaugh; J Kozak; L Rees
Journal:  Arch Clin Neuropsychol       Date:  1999-02       Impact factor: 2.813

Review 2.  Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines.

Authors:  Irene Litvan; Jennifer G Goldman; Alexander I Tröster; Ben A Schmand; Daniel Weintraub; Ronald C Petersen; Brit Mollenhauer; Charles H Adler; Karen Marder; Caroline H Williams-Gray; Dag Aarsland; Jaime Kulisevsky; Maria C Rodriguez-Oroz; David J Burn; Roger A Barker; Murat Emre
Journal:  Mov Disord       Date:  2012-01-24       Impact factor: 10.338

3.  Normative data for the Mattis Dementia Rating Scale.

Authors:  J A Lucas; R J Ivnik; G E Smith; D L Bohac; E G Tangalos; E Kokmen; N R Graff-Radford; R C Petersen
Journal:  J Clin Exp Neuropsychol       Date:  1998-08       Impact factor: 2.475

4.  Psychometric Properties of the Mattis Dementia Rating Scale

Authors: 
Journal:  Assessment       Date:  1994-06

5.  Validity of the Dementia Rating Scale in assessing cognitive function in Parkinson's disease.

Authors:  G G Brown; A A Rahill; J M Gorell; C McDonald; S J Brown; M Sillanpaa; C Shults
Journal:  J Geriatr Psychiatry Neurol       Date:  1999       Impact factor: 2.680

6.  Clinical validity of the Mattis Dementia Rating Scale-2 in Parkinson disease with MCI and dementia.

Authors:  Evelyne Matteau; Nicolas Dupré; Mélanie Langlois; Pierre Provencher; Martine Simard
Journal:  J Geriatr Psychiatry Neurol       Date:  2012-06       Impact factor: 2.680

7.  Clinical validity of the Mattis Dementia Rating Scale in differentiating mild cognitive impairment in Parkinson's disease and normative data.

Authors:  Ondrej Bezdicek; Jiri Michalec; Tomas Nikolai; Petra Havránková; Jan Roth; Robert Jech; Evžen Růžička
Journal:  Dement Geriatr Cogn Disord       Date:  2015-03-18       Impact factor: 2.959

8.  Cognitive function in early Parkinson's disease: a population-based study.

Authors:  E Elgh; M Domellöf; J Linder; M Edström; H Stenlund; L Forsgren
Journal:  Eur J Neurol       Date:  2009-06-15       Impact factor: 6.089

9.  Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia.

Authors:  Enrique Noe; Karen Marder; Karen L Bell; Diane M Jacobs; Jennifer J Manly; Yaakov Stern
Journal:  Mov Disord       Date:  2004-01       Impact factor: 10.338

10.  Subscale validity of the Mattis Dementia Rating Scale.

Authors:  D C Marson; M P Dymek; L W Duke; L E Harrell
Journal:  Arch Clin Neuropsychol       Date:  1997       Impact factor: 2.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.